Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice
Defu Li, Jian Wang, Dejun Sun, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms
Yu-Qiong He, Cancan Zhou, Luyao Yu, et al.
Pharmacological Research (2020) Vol. 163, pp. 105224-105224
Open Access | Times Cited: 285
Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways
Yuting Zhang, Wei-Ting Lu, Xiaolei Zhang, et al.
Pharmacological Research (2019) Vol. 147, pp. 104307-104307
Closed Access | Times Cited: 103
Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics
Zhong-Yan Zhou, Wai-Rong Zhao, Jing Zhang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109362-109362
Closed Access | Times Cited: 101
Hydrogen sulfide attenuates cigarette smoke-induced airway remodeling by upregulating SIRT1 signaling pathway
Ruijuan Guan, Jian Wang, Zhou Cai, et al.
Redox Biology (2019) Vol. 28, pp. 101356-101356
Open Access | Times Cited: 96
Induction of Accelerated Aging in a Mouse Model
Nanshuo Cai, Yifan Wu, Yan Huang
Cells (2022) Vol. 11, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 42
Targeting Oxidative Stress and Endothelial Dysfunction Using Tanshinone IIA for the Treatment of Tissue Inflammation and Fibrosis
Tsuo-Cheng Lu, Yi‐Hsiu Wu, Wei‐Yu Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 39
Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease
Xia Cao, Yi Wang, Ying Chen, et al.
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116229-116229
Closed Access | Times Cited: 37
Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD
Yifan Xu, Jing Li, Zhiwei Lin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Natural products: Potential therapeutic agents to prevent skeletal muscle atrophy
Aarti Yadav, Surender Singh Yadav, Sandeep Singh, et al.
European Journal of Pharmacology (2022) Vol. 925, pp. 174995-174995
Closed Access | Times Cited: 32
Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway
Ye Lu, Wenshan Zhong, Yuanyuan Liu, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108504-108504
Closed Access | Times Cited: 29
Cryptotanshinone alleviates lipopolysaccharide and cigarette smoke-induced chronic obstructive pulmonary disease in mice via the Keap1/Nrf2 axis
Hongjia Song, Jing Lü, Wanchun Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115105-115105
Open Access | Times Cited: 18
Hydrogen sulfide attenuates mitochondrial dysfunction-induced cellular senescence and apoptosis in alveolar epithelial cells by upregulating sirtuin 1
Ruijuan Guan, Zhou Cai, Jian Wang, et al.
Aging (2019) Vol. 11, Iss. 24, pp. 11844-11864
Open Access | Times Cited: 52
Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD)
Priscila Baltazar Gonçalves, Nelilma Correia Romeiro
European Journal of Medicinal Chemistry (2018) Vol. 163, pp. 911-931
Closed Access | Times Cited: 51
Slowing ribosome velocity restores folding and function of mutant CFTR
Kathryn E. Oliver, Robert Rauscher, Marjolein Mijnders, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 12, pp. 5236-5253
Open Access | Times Cited: 45
A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment
Zhangyang Bi, Yayun Wang, Caiqing Zhang
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111404-111404
Open Access | Times Cited: 39
Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways
Kajal Sherawat, Sidharth Mehan
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 8, pp. 1647-1667
Closed Access | Times Cited: 15
Sodium tanshinone IIA sulfonate inhibits proliferation, migration, invasion and inflammation in rheumatoid arthritis fibroblast-like synoviocytes
Zeyu Wang, Jinglong Li, Jun Zhang, et al.
International Immunopharmacology (2019) Vol. 73, pp. 370-378
Closed Access | Times Cited: 36
Therapeutic effect of phycocyanin on chronic obstructive pulmonary disease in mice
Wenjun Li, Yuanyuan Li, Qi Wang, et al.
Journal of Advanced Research (2024) Vol. 66, pp. 285-301
Open Access | Times Cited: 4
Effects of sodium tanshinone IIA sulfonate injection on pro-inflammatory cytokines, adhesion molecules and chemokines in Chinese patients with atherosclerosis and atherosclerotic cardiovascular disease: a meta-analysis of randomized controlled trials
Fan Xie, Xiaoying Fu, Wenbo Li, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Dietary Zinc activates the Nrf2 signaling pathway to inhibit pyroptosis and attenuate the lung inflammatory response in COPD
Yanqiu Huang, Tao Liang, Junfei Liu, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms
Zhaohui Ding, Youlin Deng, Huiming Luo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Integrating network pharmacology and molecular docking to explore the pharmacological mechanism of tanshinone IIA in improving chronic obstructive pulmonary disease
Huaiquan Liu, Shili Yang, Chen Bo, et al.
Medicine (2025) Vol. 104, Iss. 12, pp. e41638-e41638
Open Access
Integrated network pharmacology, molecular docking, and animal experiments to reveal the potential mechanism of hesperetin on COPD
Jingxi Wang, Hongyang Wang, Xin Kang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prediction of potential active ingredients and mechanism of Forsythia suspense leaf green tea extract in treating COPD mice based on UPLC‐MS and network pharmacology
Xuli Zuo, Xiuzhen Pan, Yu Wang, et al.
Journal of the Science of Food and Agriculture (2025)
Closed Access
Hydrogen gas inhalation protects against cigarette smoke-induced COPD development in mice
Wenju Lu, Defu Li, Jieying Hu, et al.
Journal of Thoracic Disease (2018) Vol. 10, Iss. 6, pp. 3232-3243
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top